Down-regulation of hepatocyte growth factor mRNA in rat cardiac myocytes under hypoxia mimicked by cobalt chloride

Clinical Hemorheology and Microcirculation

Volumn 34, Issue 1-2, 2006, Pages 201-206

  Su, Yan ^a   Li, Hongwei ^a   Zhang, Jing ^a   Xiu, Ruijuan ^a  

^a Chinese Academy of Medical Sciences   (China)

Author keywords

Cobalt chloride; Hepatocyte growth factor; Hypoxia; Hypoxia inducible factor 1a

Indexed keywords

COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SCATTER FACTOR;

ANIMAL CELL; CELL HYPOXIA; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PROTEIN FUNCTION; PROTEIN ISOLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANOXIA; CELLS, CULTURED; COBALT; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HEPATOCYTE GROWTH FACTOR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 33644804623     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, R.D. Koos and G.L. Semenza, Activition of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1, Mol. Cell Biol. 16 (1996), 4604-4613.
2. R. Bos, P.J. Diest, J.S. Jong, P. Groep, P. Valk and E. Wall, Hypoxia-inducible factor-1 is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer, Histopathology 46 (2005), 31-36.
3. T. Sakaki, K. Yamada, H. Otsuki, T. Yuguchi, E. Kohmura and T. Hayakawa, Brief exposure to hypoxia induces bFGF mRNA and protein and protects rat cortical neurons from prolonged hypoxic stress, Neurosci. Res. 23 (1995), 289-296.
4. S. Kondo, S. Kubota, T. Shimo, T. Nishida, G. Yosimichi, T. Eguchi, T. Sugahara and M. Takigawa, Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases, Carcinogenesis 23 (2002), 769-776.
5. D.F. Higgins, M.P. Biju, Y. Akai, A. Wutz, R.S. Johnson and V.H. Haase, Hypoxic induction of Ctgf is directly mediated by Hif-1, Am. J. Physiol. 287 (2004), F1223-F1232.
6. S.-I. Hayashi, R. Morishita, S. Nakamura, K. Yamamoto, A. Moriguchi, T. Nagano, M. Taiji, H. Noguchi, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara, Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease downregulation of HGF in response to hypoxia in vascular cells, Circulation 100(Suppl. II) (1999), II301-II308.
7. K. Matsumoto and T. Nakamura, Emerging multipotent aspects of hepatocyte growth factor, J. Biochem. 119 (1996), 591-600.
8. R. Van der Voort, T.E.I. Taher, P.W.B. Derksen, M. Spaargaren, R. Van der Neut and S.T. Pals, The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation, Adv. Cancer Res. 79 (2000), 39-90.
9. C. Wang, H. Li, A. Li, J. Zhang and R. Xiu, Experimental study on the function of cardiomyocyte, Clin. Hemorheol. Microcirc. 29 (2003), 369-374.
10. R. Zarnegar and G.K. Michalopoulos, The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis, J. Cell Biol. 129 (1995), 1177-1180.
11. K. Ono, A. Matsumori, T. Shioi, Y. Furukawa and S. Sasayama, Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model, Circulation 95 (1997), 2552-2558.
12. A. Matsumor, Y. Furukawa, K. Ono, T. Shioi, M. Okada, A. Iwasaki, R. Nishio and S. Sasayama, Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction, Biochem. Biophys. Res. Commun. 221 (1996), 391-395.
13. T. Soeki, Y. Tamura, H. Shinohara, H. Tanaka, K. Bando and N. Fukuda, Serial changes in serum VEGF and HGF in patients with acute myocardial infarction, Cardiology 93 (2000), 168-174.
14. Y. Zhu, Y. Hojo, U. Ikeda and K. Shimada, Production of hepatocyte growth factor during acute myocardial infarction, Heart 83 (2000), 450-455.
15. T. Sato, T. Yoshinouchi, T. Sakamoto, H. Fujieda, S. Murao, H. Sato, H. Kobayashi and T. Ohe, Hepatocyte growth factor (HGF): a new biochemical marker for acute myocardial infarction, Heart Vessels 12 (1997), 241-246.
16. W. Schaper and T. Kubin, Is hepatocyte growth factor a protein with cardioprotective activity in the ischemic heart?, Circulation 95 (1997), 2471-2472.
17. K. Guillemin and M.A. Krasnow, The hypoxic response: Huffing and HIFing, Cell 89 (1997), 9-12.
18. G.L. Wang and G.L. Senenza, Purification and characterization of hypoxia-inducible factor1, J. Biol. Chem. 270 (1995), 1230-1237.
19. 2 tension, Proc. Natl. Acad. Sci. USA 92 (1995), 5510-5514.
20. 2 homeostasis by hypoxia-inducible factor 1, Ann. Rev. Cell Dev. Biol. 15 (1999), 551-578.
21. 2-dependent degradation domain via the ubiquitin-proteasome pathway, Proc. Natl. Acad. Sci. USA 95 (1998), 7987-7992.
22. P.J. Kallio, W.J. Wilson, S. O'Brien, Y. Makino and L. Poellinger, Regulation of the hypoxia-inducible factor 1α by the ubiquitin-proteasome pathway, J. Biol. Chem. 274 (1992), 5519-6525.
23. C.H. Sutter, E. Laughner and G.L. Semenza, Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations, Proc. Natl. Acad. Sci. USA 97 (2000), 4748-4753.
24. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher and P.J. Ratcliffe, The tumor suppressor protein VHL targets Hypoxia-inducible factors for oxygen-dependent proteolysis, Nature 399 (1999), 271-275.
25. 2-regulated prolyl hydroxylation, Science 292 (2001), 468-472.
26. 2 sensing, Science 292 (2001), 464-468.
27. 2 homeostasis, Curr. Opin. Genet. Dev. 8 (1998), 588-594.
28. Y.S. Chun, M.S. Kim and J.W. Park, Oxygen-dependent and -independent regulation of HIF-1α, J. Korean Med. Sci. 17 (2002), 581-588.
29. A. Minchenko, S. Salceda, T. Bauer and J. Caro, Hypoxia regulatory elements of the human vascular endothelial growth factor gene, Cell Mol. Biol. Res. 40 (1994), 35-39.
30. B.H. Jiang, E. Rue, G.L. Wang, R. Roe and G.L. Semenza, Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1, J. Biol. Chem. 271 (1996), 17771-17778.
31. S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano and P.M. Comoglio, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell 3 (2003), 347-361.
32. S. Scarpino, F. Cancellario d'Alena, A. Di Napoli, A. Pasquini, A. Marzullo and L.P. Ruco, Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumor cells in papillary carcinoma of the thyroid, J. Pathol. 202 (2004), 352-358.
33. W.W. Simmons, E.I. Cross, J.M. Cunningham, T.W. Smith and R.A. Kelly, Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes, J. Biol. Chem. 271 (1996), 11694-11702.
34. J.P. Springhorn and W.C. Claycomb, Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells, Biochem. J. 258 (1989), 73-78.
35. M. Tamura, N. Arakaki, H. Tsubouchi, H. Takada and Y. Daikuhara, Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture, J. Biol. Chem. 268 (1993), 8140-8145.
36. A. Okajima, K. Miyazawa and N. Kitamura, Characterization of the rat hepatocyte-growth-factor/scatter-factor gene, Eur. J. Biochem. 213 (1993), 113-119.
37. M. Manganini and J.A. Maier, Transforming growth factor beta2 inhibition of hepatocyte growth factor induced endothelia proliferation and migration, Oncogene 19 (2000), 124-133.
38. B. Aravamudan, M. Watabe and K. Watabe, Characterization of the 5′-flanking region of the hepatocyte growth factor gene, Biochem. Biophys. Res. Commun. 195 (1993), 346-353.
39. H.O. Akman, H. Zhang, M.A.Q. Siddiqui, W. Solomon, E.L.P. Smith and O.A. Batuman, Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelia cells. Blood 98 (2001), 3324-3331.
40. H.G. Zhang and R. Xiu, Micro-vascular medicine and protemics, Clin. Hemorheol. Microcirc. 29 (2003), 189-192.